The NLRP1 Inflammasome Attenuates Colitis and Colitis-Associated Tumorigenesis
Open accessThe DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Nucleotide-binding domain and leucine-rich repeat (NLR) proteins are a diverse family of pattern recognition receptors that are essential mediators of inflammation and host defense in the gastrointestinal system. Recent studies have identified a subgroup of inflammasome forming NLRs that modulate the mucosal immune response during inflammatory bowel disease (IBD) and colitis associated tumorigenesis. To better elucidate the contribution of NLR family members in IBD and cancer, we conducted a retrospective analysis of gene expression metadata from human patients. These data revealed that NLRP1, an inflammasome forming NLR, was significantly dysregulated in IBD and colon cancer. To better characterize the function of NLRP1 in disease pathogenesis, we used Nlrp1b(-/-) mice in colitis and colitis-associated cancer models. In this paper, we report that NLRP1 attenuates gastrointestinal inflammation and tumorigenesis. Nlrp1b(-/-) mice demonstrated significant increases in morbidity, inflammation, and tumorigenesis compared with wild-type animals. Similar to data previously reported for related inflammasome forming NLRs, the increased inflammation and tumor burden was correlated with attenuated levels of IL-1β and IL-18. Further mechanistic studies using bone marrow reconstitution experiments revealed that the increased disease pathogenesis in the Nlrp1b(-/-) mice was associated with nonhematopoietic-derived cells and suggests that NLRP1 functions in the colon epithelial cell compartment to attenuate tumorigenesis. Taken together, these data identify NLRP1 as an essential mediator of the host immune response during IBD and cancer. These findings are consistent with a model whereby multiple NLR inflammasomes attenuate disease pathobiology through modulating IL-1β and IL-18 levels in the colon.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Commensal bacteria and their bioproducts induce inflammasomes activation and IL-18 production in the gut, which, in turn, prevents intestinal barrier disruption and dysbiosis [121,124,131,132,133].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [132]
Experimental — accuracy not yet measuredIn the citing paper
“Dysbiosis has been observed in mice deficient for inflammasomes components, including NLRP6, ASC, caspase-1, and IL-18 [131,132,133,134].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066 · cited 4×
“Although exposure to either T. gondii or LeTx are unlikely mediators of IBD pathogenesis, further characterization of NLRP1 will likely identify a range of additional MAMPs and DAMPs of greater relevance to gastrointestinal inflammation and cancer.”
InfluentialSchroder, K., & Tschopp, J. (2010) · Cell · doi:10.1016/j.cell.2010.01.040 · Cited by 5,475
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024 · cited 4×
“For example, the commensal microbiota composition in the Nlrp6 mice was found to be significantly altered compared with WT animals, and this distorted microbiota was suggested to be directly associated with disease pathogenesis in IBD (6, 14).”
BackgroundResultInfluentialAcosta-Rodriguez, E. V., Napolitani, G., Lanzavecchia, A., & Sallusto, F. (2007) · Nature Immunology · doi:10.1038/ni1496 · Cited by 1,857
Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf
Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., & Dixit, V. M. (2004) · Nature · doi:10.1038/nature02664 · Cited by 1,839
Chemically induced mouse models of intestinal inflammation
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007) · Nature Protocols · doi:10.1038/nprot.2007.41 · Cited by 1,567 · cited 2×
“5 or 5% DSS (MP Biomedicals) for 4–5 d and the mice were evaluated for up 10 d (33).”
BackgroundSutton, C. E., Lalor, S. J., Sweeney, C. M., Brereton, C. F., Lavelle, E. C., & Mills, K. H. G. (2009) · Immunity · doi:10.1016/j.immuni.2009.08.001 · Cited by 1,553
Critical Regulation of Early Th17 Cell Differentiation by Interleukin-1 Signaling
Chung, Y., Chang, S. H., Martinez, G. J., Yang, X. O., Nurieva, R., Kang, H. S., Ma, L., Watowich, S. S., Jetten, A. M., Tian, Q., et al. (2009) · Immunity · doi:10.1016/j.immuni.2009.02.007 · Cited by 1,199
Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M., & Kanneganti, T.-D. (2010) · Immunity · doi:10.1016/j.immuni.2010.03.003 · Cited by 989 · cited 3×
“Specifically, Asc(2) /2 and Casp1/11 mice develop severe gastrointestinal inflammation and colon tumorigenesis in AOM/DSS models (4, 5, 8).”
BackgroundResult
Cited by
Pyroptosis: Mechanisms and Diseases
Yu, P., Zhang, X., Liu, N., Tang, L., Peng, C., & Chen, X. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00507-5 · Cited by 2,353
“Deletion of Nlrp1b significantly increased morbidity and tumorigenesis in mice.(282) In addition, Nlrp3 (−/−) mice also showed recurrent colitis and increased colitis-associated cancer.”
BackgroundFerroptosis, necroptosis, and pyroptosis in anticancer immunity
Tang, R., Xu, J., Zhang, B., Liu, J., Liang, C., Hua, J., Meng, Q., Yu, X., & Shi, S. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00946-7 · Cited by 1,273
Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy
Gao, W., Wang, X., Zhou, Y., Wang, X., & Yu, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01046-3 · Cited by 1,042
The role of pyroptosis in cancer: pro-cancer or pro-“host”?
Xia, X., Wang, X., Cheng, Z., Qin, W., Lei, L., Jiang, J., & Hu, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1883-8 · Cited by 856
Diverging inflammasome signals in tumorigenesis and potential targeting
Karki, R., & Kanneganti, T.-D. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0123-y · Cited by 641
Gut Microbiota and Cancer: From Pathogenesis to Therapy
Vivarelli, S., Salemi, R., Candido, S., Falzone, L., Santagati, M., Stefani, S., Torino, F., Banna, G. L., Tonini, G., & Libra, M. (2019) · Cancers · doi:10.3390/cancers11010038 · Cited by 586
A 360° view of the inflammasome: Mechanisms of activation, cell death, and diseases
Barnett, K. C., Li, S., Liang, K., & Ting, J. P.-Y. (2023) · Cell · doi:10.1016/j.cell.2023.04.025 · Cited by 458
Karki, R., Man, S. M., & Kanneganti, T.-D. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0269 · Cited by 377
“In mice, the NLRP1b inflammasome provides protection against colon tumorigenesis, mediating secretion of both IL1b and IL18 in stromal cells of the colon (18).”
Inflammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis
Man, S. M. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0054-1 · Cited by 302
“Injection of recombinant IL-18 reduces intestinal inflammation and tumour burden in inflammasome-deficient mice that had been administered AOM and DSS; the same treatment also ameliorated colitis in inflammasome-deficient mice exposed to the chemical colitogen oxazolone 183, 187, 204, 211, 214 .”
BackgroundInfluentialMolecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity
Hou, J., Hsu, J.-M., & Hung, M.-C. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.09.003 · Cited by 301
Focus on the Role of NLRP3 Inflammasome in Diseases
Fusco, R., Siracusa, R., Genovese, T., Cuzzocrea, S., & Di Paola, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124223 · Cited by 290
Harnessing innate immune pathways for therapeutic advancement in cancer
Hu, A., Sun, L., Lin, H., Liao, Y., Yang, H., & Mao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01765-9 · Cited by 255
Bioactive Compounds Isolated from Microalgae in Chronic Inflammation and Cancer
Talero, E., García-Mauriño, S., Ávila-Román, J., Rodríguez-Luna, A., Alcaide, A., & Motilva, V. (2015) · Marine Drugs · doi:10.3390/md13106152 · Cited by 255
Malik, A., Sharma, D., Malireddi, R. K. S., Guy, C. S., Chang, T.-C., Olsen, S. R., Neale, G., Vogel, P., & Kanneganti, T.-D. (2018) · Immunity · doi:10.1016/j.immuni.2018.08.024 · Cited by 196
NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies
Liu, P., Lu, Z., Liu, L., Li, R., Liang, Z., Shen, M., Xu, H., Ren, D., Ji, M., Yuan, S., et al. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152925 · Cited by 173
Pyrin Inflammasome Regulates Tight Junction Integrity to Restrict Colitis and Tumorigenesis
Sharma, D., Malik, A., Guy, C. S., Karki, R., Vogel, P., & Kanneganti, T.-D. (2018) · Gastroenterology · doi:10.1053/j.gastro.2017.11.276 · Cited by 162
NOD-like receptors in autoimmune diseases
Chen, L., Cao, S., Lin, Z., He, S., & Zuo, J. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00603-2 · Cited by 154
Zhou, C., & Fang, J. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.05.001 · Cited by 161
Context-dependent functions of pattern recognition receptors in cancer
Man, S. M., & Jenkins, B. J. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00462-5 · Cited by 151
Epithelial Cell Inflammasomes in Intestinal Immunity and Inflammation
Lei, A., Murphy, A. G., & Maloy, K. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01168 · Cited by 150
“In addition, several studies demonstrated that rIL-18 administration rescued inflammasome-deficient phenotypes from hypersusceptibility to DSS colitis (32, 47, 51, 52, 131).”
BackgroundInflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development
Kantono, M., & Guo, B. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01132 · Cited by 133
Abraham, C., Abreu, M. T., & Turner, J. R. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.288 · Cited by 128
Inflammation in cancer: therapeutic opportunities from new insights
Xie, Y., Liu, F., Wu, Y., Zhu, Y., Jiang, Y., Wu, Q., Dong, Z., & Liu, K. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02243-8 · Cited by 167
Inflammasomes and intestinal inflammation
Zmora, N., Levy, M., Pevsner-Fishcer, M., & Elinav, E. (2017) · Mucosal Immunology · doi:10.1038/mi.2017.19 · Cited by 139
“Complementation of these cytokines during DSS treatment attenuated disease severity, hinting at their role as mediators of NLRP1b-induced protection in this model.(109) NLRP1 expression was examined in human patients with colorectal cancer, and was found to be reduced in tumors as compared with adjacent healthy tissue…”
BackgroundHu, S., Peng, L., Kwak, Y.-T., Tekippe, E. M., Pasare, C., Malter, J. S., Hooper, L. V., & Zaki, M. H. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.040 · Cited by 121
“inflammasome in the gut can be activated by other PRRs, such as NLRP1 and NLRP6, which also contribute to intestinal homeostasis (Elinav et al., 2011; Williams et al., 2015).”
Yuan, Y., Xie, K.-X., Wang, S.-L., & Yuan, L. (2018) · Gastroenterology report · doi:10.1093/gastro/goy011 · Cited by 134
NLRP1 restricts butyrate producing commensals to exacerbate inflammatory bowel disease
Tye, H., Yu, C.-H., Simms, L. A., de Zoete, M. R., Kim, M. L., Zakrzewski, M., Penington, J. S., Harapas, C. R., Souza-Fonseca-Guimaraes, F., Wockner, L. F., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06125-0 · Cited by 110
Sun, J., Chen, F., & Wu, G. (2023) · The ISME Journal · doi:10.1038/s41396-023-01483-0 · Cited by 127
Inflammasomes of the intestinal epithelium
Sellin, M. E., Maslowski, K. M., Maloy, K. J., & Hardt, W. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.002 · Cited by 101
Inflammasome signaling in colorectal cancer
Sharma, B. R., & Kanneganti, T. (2022) · Translational research · doi:10.1016/j.trsl.2022.09.002 · Cited by 103
Epigenetic Mechanisms of Inflammasome Regulation
Poli, G., Fabi, C., Bellet, M. M., Costantini, C., Nunziangeli, L., Romani, L., & Brancorsini, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165758 · Cited by 80
Deswaerte, V., Nguyen, P. M., West, A. C., Browning, A. F., Yu, L., Ruwanpura, S. M., Balic, J. J., Livis, T., Girard, C., Preaudet, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1887 · Cited by 91
Pyroptosis in Cancer: Friend or Foe?
Lu, X., Guo, T., & Zhang, X. (2021) · Cancers · doi:10.3390/cancers13143620 · Cited by 92
Inflammasome inhibitors: promising therapeutic approaches against cancer
Xu, S., Li, X., Liu, Y., Xia, Y., Chang, R., & Zhang, C. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0755-0 · Cited by 86
“Xu Z, Wang H, Wei S, Wang Z, Ji G. Inhibition of ER stress-related IRE1alpha/ CREB/NLRP1 pathway promotes the apoptosis of human chronic myelogenous leukemia cell.”
BackgroundInfluentialMicrobiota as a mediator of cancer progression and therapy
Pope, J. L., Tomkovich, S., Yang, Y., & Jobin, C. (2017) · Translational Research · doi:10.1016/j.trsl.2016.07.021 · Cited by 79
Dynamic roles of inflammasomes in inflammatory tumor microenvironment
Jang, J., Kim, D., & Surh, Y. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00154-7 · Cited by 86
Bacterial Peptidoglycan Fragments Differentially Regulate Innate Immune Signaling
Bersch, K. L., DeMeester, K. E., Zagani, R., Chen, S., Wodzanowski, K. A., Liu, S., Mashayekh, S., Reinecker, H., & Grimes, C. L. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00200 · Cited by 90
Nonessential Role for the NLRP1 Inflammasome Complex in a Murine Model of Traumatic Brain Injury
Brickler, T., Gresham, K., Meza, A., Coutermarsh-Ott, S., Williams, T. M., Rothschild, D. E., Allen, I. C., & Theus, M. H. (2016) · Mediators of Inflammation · doi:10.1155/2016/6373506 · Cited by 72
“In the present study, we utilized NLRP1 and ASC gene targeted knockout mice, which have been previously shown to prevent NLRP1-mediated inflammasome complex formation during acute inflammation [17, 18, 36].”
MethodSelf-citation(2022) · doi:10.1016/j.hsr.2021.100010 · Cited by 69
Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective
Khan, M. B., Ai, M.-L., Du, K., Song, J., Wang, B., Lin, J., Ren, A., Chen, C., Huang, Z., Qiu, W., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1062225 · Cited by 73
Polymorphic Immune Mechanisms Regulate Commensal Repertoire
Khan, A. A., Yurkovetskiy, L., O’Grady, K., Pickard, J. M., de Pooter, R., Antonopoulos, D. A., Golovkina, T., & Chervonsky, A. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.010 · Cited by 67
The contrasting roles of inflammasomes in cancer.
He, Q., Fu, Y., Tian, D., & Yan, W. (2018) · Europe PMC (PubMed Central) · Cited by 73
Divergent Roles for the IL-1 Family in Gastrointestinal Homeostasis and Inflammation
McEntee, C. P., Finlay, C. M., & Lavelle, E. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01266 · Cited by 70
“Furthermore, barrier integrity is compromised in these mice and they have been shown to exhibit elevated levels of serum endotoxin as well as bacterial translocation compared to wild-type mice (109).”
BackgroundNOD-like Receptor Signaling Pathway in Gastrointestinal Inflammatory Diseases and Cancers
Zhou, Y., Yu, S., & Zhang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914511 · Cited by 79
“[141] NOD2 Udden et al. NOD2 inhibited colorectal cancer by downregulating TLR-mediated NF-κ B and MAPK pathways [142] It is reported that NLRC3, NLRP1b (a subfamily of NLRP1), NLRP3, NLRP6 and NLRP12 play an important role in preventing the occurrence of CRC [36,134,143–145].”
BackgroundThe microbiome and cytosolic innate immune receptors
Liwinski, T., Zheng, D., & Elinav, E. (2020) · Immunological Reviews · doi:10.1111/imr.12901 · Cited by 65
Role of pyroptosis in cancer and its therapeutic regulation
Mamun, A. A., Mimi, A. A., Aziz, M. A., Zaeem, M., Ahmed, T., Munir, F., & Xiao, J. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174444 · Cited by 59
Watanabe, D., Guo, Y., & Kamada, N. (2021) · EMBO Molecular Medicine · doi:10.15252/emmm.202013452 · Cited by 61
“Further, a retrospective analysis of metadata from colonic mucosal biopsies collected from patients with active ulcerative colitis (UC) revealed a higher expression level of NLRP1 (Williams et al , 2015).”
InfluentialStructural basis for thioredoxin-mediated suppression of NLRP1 inflammasome
Zhang, Z., Shibata, T., Fujimura, A., Kitaura, J., Miyake, K., Ohto, U., & Shimizu, T. (2023) · Nature · doi:10.1038/s41586-023-06532-4 · Cited by 53
Wang, Z., Zeng, F., Hu, Y., Wang, X., Zhao, F., Zhou, P., Hu, J., Xiao, Y., Hu, Z., Guo, M., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00820-z · Cited by 57
Tumor-intrinsic determinants of immunogenic cell death modalities
Workenhe, S. T., Pol, J. G., & Kroemer, G. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1893466 · Cited by 53
The roles of inflammasomes in cancer
Deng, Z., Lu, L., Li, B., Shi, X., Jin, H., & Hu, W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1195572 · Cited by 55
“NLRP1 expression levels were downregulated in biopsied tissues of colon cancer patients compared with healthy controls, suggesting that NLRP1 can act as a key regulator of colon homeostasis (41).”
BackgroundInfluentialInflammatory cell death in intestinal pathologies
Sharma, D., & Kanneganti, T. (2017) · Immunological Reviews · doi:10.1111/imr.12602 · Cited by 51
“Salmonella infection Susceptible Increased TUNEL (+) and cl- casp- 3 (+) (178) Nlrp1b−/− DSS Susceptible Increased TUNEL (+) cells (123)”
BackgroundScarpitta, A., Hacker, U. T., Büning, H., Boyer, O., & Adriouch, S. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.731598 · Cited by 51
Asbestos-Induced Mesothelial to Fibroblastic Transition Is Modulated by the Inflammasome
Thompson, J. K., MacPherson, M. B., Beuschel, S. L., & Shukla, A. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.11.008 · Cited by 44
Pyroptosis: shedding light on the mechanisms and links with cancers
You, H., Wang, L., Meng, H., Huang, C., Fang, G.-Y., & Li, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1290885 · Cited by 44
Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis
Bi, Q., Wu, J., Qiu, X., Zhang, J., Sun, Z., & Wang, W. (2022) · Journal of Immunology Research · doi:10.1155/2022/3128933 · Cited by 52
“However, in contrast, deleting the Aim2 [129], Asc [129, 130], Nlrp3 [131, 132], Nlrc4 [133], Casp1 [132, 133], or Il-18r [134] genes invariably exacerbated the burden of AOM/DSS-induced colorectal cancer in mice.”
What role does pyroptosis play in cancer?
Huang, C. L., Li, J., & Zhang, C. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101587 · Cited by 44
“Tong and colleagues identified the miR-145/GSDMD signaling pathway as a key mediator of tanshinone II’s action on HeLa cells [90].”
BackgroundInfluentialPyroptosis and inflammasomes in cancer and inflammation
Wang, J., Hua, S., Bao, H., Yuan, J., Zhao, Y., & Chen, S. (2023) · MedComm · doi:10.1002/mco2.374 · Cited by 47
NLR-regulated pathways in cancer: opportunities and obstacles for therapeutic interventions
Sharma, N., & Jha, S. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2123-8 · Cited by 44
“have shown significant dysregulation of NLRP1, inflammasome forming NLR in inflammatory bowel disease and colitis-associated cancer [109].”
BackgroundWang, Z., Chen, T., Yang, C., Bao, T., Yang, X., He, F., Zhang, Y.-T. Y., Zhu, L., Chen, H., Rong, S., et al. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.105931 · Cited by 44
Soares, J. L. S., Fernandes, F. P., Patente, T. A., Monteiro, M. B., Parisi, M. C. R., Giannella‐Neto, D., Corrêa‐Giannella, M. L., & Pontillo, A. (2017) · Clinical Immunology · doi:10.1016/j.clim.2017.10.003 · Cited by 39
Subramaniam, R., Mizoguchi, A., & Mizoguchi, E. (2016) · Cancer Research Frontiers · doi:10.17980/2016.1 · Cited by 46
“Expression analysis of various NLRs in colon cancer tissue from human patients resulted in significant down-regulation of NLRP1, upregulation of NLRP3 and NLRC4, and unchanged NLRP6 (47).”
InfluentialNLRP1 Overexpression Is Correlated with the Tumorigenesis and Proliferation of Human Breast Tumor
Wei, Y., Huang, H., Qiu, Z., Li, H., Tan, J., Ren, G., & Wang, X. (2017) · BioMed Research International · doi:10.1155/2017/4938473 · Cited by 41
“Inversely, other authors demonstrated thatNLRP1 attenuates colitis and colitis-associated tumorigenesis [17].”
BackgroundInflammasomes in Colitis and Colorectal Cancer: Mechanism of Action and Therapies.
Pandey, A., Shen, C. X., & Man, S. M. (2019) · Europe PMC (PubMed Central) · Cited by 53
Regulation of the gut microbiome by inflammasomes
Chen, G. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.011 · Cited by 38
“Importantly, administration of recombinant IL-18 into caspase-1, Nlrp1 or Nlrp3 mice ameliorated colitis [35,37,42].”
InfluentialTo protect or adversely affect? The dichotomous role of the NLRP1 inflammasome in human disease
Tupik, J. D., Nagai-Singer, M. A., & Allen, I. C. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100858 · Cited by 40
Self-citationKumar, V., Mansfield, J. A., Fan, R., MacLean, A. G., Li, J., & Mohan, M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701148 · Cited by 35
“9 (IRF9)], antimicrobial response/mucus barriers [oral a defensin 1 (ROAD-1), a-defensin 2 (MNP2), defensin a 4 (DEFA4), defensin-7-like, b defensin 122, a-defensin 6 precursor, mucin 2 (MUC2)], inflammasome signaling [NLR family, pyrin domain containing 7, (NLRP7), NLR family, pyrin domain containing 1 (NLRP1) (45),…”
BackgroundChen, F., Wu, Y.-L., Cheng, C., Hsiao, Y., Chi, J.-Y., Hung, L., Chang, C., Lai, M., & Wang, J. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-023-00991-7 · Cited by 35
“In the antitumor role of pyroptosis, pyroptosis-induced inflammasome activation suppresses tumorigenesis in colitis-associated colon cancer [57–59].”
BackgroundFlood, B., Manils, J., Nulty, C., Flis, E., Kenealy, S., Barber, G. L., Fay, J., Mills, K. H. G., Kay, E. W., & Creagh, E. M. (2018) · Oncogene · doi:10.1038/s41388-018-0613-5 · Cited by 34
Costa, F. R. C., Leite, J. A., Rassi, D. M., da Silva, J. F., Elias‐Oliveira, J., Guimarães, J. B., Foss‐Freitas, M. C., Câmara, N. O. S., Pontillo, A., Tostes, R. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109176 · Cited by 32
Inflammasomes in cancer: Effect of epigenetic and autophagic modulations
Mishra, S. R., Mahapatra, K. K., Behera, B. P., Bhol, C. S., Praharaj, P. P., Panigrahi, D. P., Patra, S., Singh, A., Patil, S., Dhiman, R., et al. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.09.013 · Cited by 31
Ringel-Scaia, V. M., McDaniel, D. K., & Allen, I. C. (2016) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.2017019158 · Cited by 32
Self-citationPolymorphisms in NLRP1 Gene Are Associated with Type 1 Diabetes
Sun, X., Xia, Y., Liu, Y., Wang, Y., Luo, S., Lin, J., Huang, G., Li, X., Xie, Z., & Zhou, Z. (2019) · Journal of Diabetes Research · doi:10.1155/2019/7405120 · Cited by 31
“Moreover, recent findings have shown that NLRP1 could protect against metabolic syndrome [37] as well as colitis-associated tumorigenesis [38], which indicates that NLRP1 possibly acts as a homeostatic factor.”
BackgroundInflammasomes in Myeloid Cells: Warriors Within
Jha, S., Brickey, W. J., & Ting, J. P.-Y. (2017) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0049-2016 · Cited by 35
“Aside from response to microbial pathogens, NLRP1 is associated with several disease pathologies, including acute glaucoma, traumatic brain injury, acute lung injury, colitis, and colitis-associated tumorigenesis (29, 35 – 37).”
BackgroundCaspase-4 and -5 Biology in the Pathogenesis of Inflammatory Bowel Disease
Smith, A. P., & Creagh, E. M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.919567 · Cited by 31
Gastrointestinal microbiota and inflammasomes interplay in health and disease: a gut feeling
Luca, R. D., Arrè, V., Nardone, S., Incerpi, S., Giannelli, G., Trivedi, P., Anastasiadou, E., & Negro, R. (2025) · Gut · doi:10.1136/gutjnl-2025-334938 · Cited by 37
“While Williams et al showed that NLRP1-deficient mice, which exhibit low levels of IL-1 β and IL-18, are more vulnerable to developing colitis than their wild-type counterparts, 37 another Figure 1 Overview of the microbiota-derived pathological outcomes.”
Rothschild, D. E., Zhang, Y., Diao, N., Lee, C. K., Chen, K., Caswell, C. C., Slade, D. J., Helm, R. F., LeRoith, T., Li, L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.039 · Cited by 29
“Colon H&E sections were evaluated and scored as previously described (Williams et al., 2015b).”
InfluentialSelf-citationXu, Q., Sun, W., Zhang, J., Mei, Y., Bao, J., Hou, S., Zhou, X., & Mao, L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.963291 · Cited by 33
Characterization of genetic subclonal evolution in pancreatic cancer mouse models
Niknafs, N., Zhong, Y., Moral, J. A., Zhang, L., Shao, M. X., Lo, A., Makohon-Moore, A. P., Iacobuzio–Donahue, C. A., & Karchin, R. (2019) · Nature Communications · doi:10.1038/s41467-019-13100-w · Cited by 28
Zhou, Z., Dong, J., Qiu, Y., Zhang, G., Wei, K., He, L., Sun, Y., Jiang, H., Zhang, S., Guo, X., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116706 · Cited by 32
Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis
Wang, S., He, H., Qu, L., Shen, Q., & Dai, Y. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1446486 · Cited by 38
Targeting inflammasomes as an immunotherapeutic strategy for cancer
Huang, L., Chen, X., Liu, R., Nan, D., Bao, W., Yang, L., Dai, X., Tang, J., Zhang, H., & Lu, Y. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06665-2 · Cited by 28
“This highlights the involvement of NLRP1 in colonic epithelial cell compartments, mitigating tumor development, with significant implications for host immune responses during IBD and cancer [71].”
Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer
Looi, C.-K., Hii, L., Chung, F. F., Mai, C., Lim, W., & Leong, C. (2021) · Cancers · doi:10.3390/cancers13081786 · Cited by 26
Wang, W., Xu, S.-W., Teng, Y., Zhu, M., Guo, Q., Wang, Y., Mao, X., Li, S.-W., & Luo, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.779123 · Cited by 28
“The expression of NLRP1 in colorectal cancer was decreased compared with normal tissues, and a higher tumor incidence was observed in NLRP1−/− mice (Williams et al., 2015).”
BackgroundGeneral Strategies in Inflammasome Biology
Dubois, H., Wullaert, A., & Lamkanfi, M. (2016) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-41171-2_1 · Cited by 31
Han, Y., Park, J., Cha, J.-Y., Jeong, M., Go, E., & Hahm, K. B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29956 · Cited by 24
Differential Peptidoglycan Recognition Assay Using Varied Surface Presentations
D’Ambrosio, E. A., Bersch, K. L., Lauro, M. L., & Grimes, C. L. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c03933 · Cited by 23
Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease
Xu, Q., Zhou, X., Strober, W., & Mao, L. (2021) · Molecules · doi:10.3390/molecules26061725 · Cited by 28
“[108] who showed that Nlrp1b-deficient mice exhibited intensified colitis induced by DSS as compared to wild-type mice.”
BackgroundNew prospects of cancer therapy based on pyroptosis and pyroptosis inducers
Chen, Q., Sun, Y., Wang, S., & Xu, J. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01906-5 · Cited by 25
“Studies have indicated reduced expression of NLRP1 in lung adenocarcinoma (LUAD) [ 81] and colon cancer tissues [82] compared to that in normal tissues.”
Santana, P. T., de Lima, I. S., Souza, K. C. D. S. E., Barbosa, P. H. S., & de Souza, H. S. P. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252010874 · Cited by 28
“Reduced NLRP1 expression was found in colon cancer tissues compared to healthy controls, indicating its role in maintaining colon homeostasis [118].”
BackgroundPyroptosis: a new insight into intestinal inflammation and cancer
Chao, L., Zhang, W., Feng, Y., Gao, P., & Ma, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1364911 · Cited by 26
Gut microbiota-mediated activation of GSDMD ignites colorectal tumorigenesis
Chen, J., Singh, N., Ye, X., Theune, E. V., & Wang, K. (2024) · Cancer Gene Therapy · doi:10.1038/s41417-024-00796-2 · Cited by 24
Song, W., Liu, Z., Wang, K., Tan, K., Zhao, A., Li, X., Yuan, Y., & Yang, Z. (2022) · Discover Oncology · doi:10.1007/s12672-022-00495-0 · Cited by 20
Ringel-Scaia, V. M., Qin, Y., Thomas, C. A., Huie, K. E., McDaniel, D. K., Eden, K. B., Wade, P. A., & Allen, I. C. (2019) · Journal of Innate Immunity · doi:10.1159/000495850 · Cited by 24
Self-citationLi, Z.-Z., Shen, L., Li, Y.-Y., Shen, L., & Li, N. (2022) · Cancer Medicine · doi:10.1002/cam4.4825 · Cited by 16
Li, G. Q., Gao, S. X., Wang, F. H., Kang, L., Tang, Z. Y., & Xiao, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115019 · Cited by 26
Immunogenicity of cancer cells: An overview
Singh, T., Bhattacharya, M., Mavi, A. K., Gulati, A., Rakesh, Sharma, N. K., Gaur, S., & Kumar, U. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110952 · Cited by 22
GFI1 downregulation promotes inflammation-linked metastasis of colorectal cancer
Xing, W., Xiao, Y., Lu, X., Zhu, H., He, X., Huang, W., Sánchez‐López, E., Wong, J., Ju, H., Tian, L., et al. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2017.50 · Cited by 22
“Inflammation greatly contributes to CRC development and progression.(20,35,36) In the present study, we identified an inflammatory environment-mediated transcriptional programme that controls themetastatic potential of CRC through GFI1, a transcriptional repressor.”
BackgroundOliveira, D. M., Santamaria, G., Laudanna, C., Migliozzi, S., Zoppoli, P., Quist, M. J., Grasso, C., Mignogna, C., Elia, L., Faniello, M. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24912 · Cited by 21
“Among the “common genes” presenting CN losses identified in this study is NLRP1, a protein whose function is apparently involved in gastrointestinal inflammation and tumorigenesis [62].”
Prognostic Role of Inflammasome Components in Human Colorectal Cancer
Domblides, C., Soubeyran, I., Lartigue, L., Mahouche, I., Lefort, F., Velasco, V., Barnetche, T., Blanco, P., Déchanet‐Merville, J., & Faustin, B. (2020) · Cancers · doi:10.3390/cancers12123500 · Cited by 20
“Indeed, in NLRP1-/- mice in hematopoietic or non-hematopoietic cells, it was shown that epithelial but not immune, expression of NLRP1 limited tumorigenesis [34].”
Background
Metadata
- Authors
- Williams, T. M., Leeth, R. A., Rothschild, D. E., Coutermarsh-Ott, S. L., McDaniel, D. K., Simmons, A. E., Heid, B., Cecere, T. E., & Allen, I. C.
- Affiliations
- Virginia–Maryland College of Veterinary Medicine (US)
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech , Blacksburg, VA 24061
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-04-01
- Volume
- 194
- Issue
- 7
- Pages
- 3369-3380
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- PMC
- PMC4369420
- OpenAlex
- W1632263489
- Cited by
- 162
- References
- 62
- Citations by year
- 2026: 5 · 2025: 12 · 2024: 21 · 2023: 20 · 2022: 18 · 2021: 18 · 2020: 9 · 2019: 13 · 2018: 12 · 2017: 18 · 2016: 9 · 2015: 6
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- The Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of General Medical Sciences (R25GM072767, R25GM066534)
- National Institute of Diabetes and Digestive and Kidney Diseases (K01DK092355)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NLRP1, inflammasome, colitis, colitis-associated tumorigenesis, inflammatory bowel disease, colon cancer, IL-1β, IL-18, colonic epithelial cells, gene expression dysregulation, host immune response
- MeSH terms
- NLR Proteins, Animals, Biopsy, Cell Transformation, Neoplastic, Colitis, Colitis, Ulcerative, Colonic Neoplasms, Disease Models, Animal, Humans, Male, Retrospective Studies, Gene Expression, Mice, Knockout, Disease Progression, Interleukin-18, Adaptor Proteins, Signal Transducing, Apoptosis Regulatory Proteins, Mice, Interleukin-1beta, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.